Hairy cell leukemia natural history: Difference between revisions

Jump to navigation Jump to search
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hairy cell leukemia}}
{{Hairy cell leukemia}}
{{CMG}} {{AE}}{{HL}}
{{CMG}}; {{AE}} {{HL}} {{VKG}}


==Overview==
==Overview==
Most patients with hairy cell leukemia are asymptomatic at the time of diagnosis. If left untreated, most of the patients with hairy cell leukemia will gradually develop [[anemia]], recurrent infections, and [[bleeding]]. The complications of hairy cell leukemia are mainly due to [[bone marrow failure]].
Most patients with [[hairy cell leukemia]] are asymptomatic at the time of diagnosis. If left untreated, most of the patients with [[hairy cell leukemia]] will gradually develop [[anemia]], recurrent infections, and [[bleeding]]. The complications of hairy cell leukemia are mainly due to [[bone marrow failure]].


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


=== Natural History ===
=== Natural History ===
 
* Most patients with [[hairy cell leukemia]] are [[asymptomatic]] at the time of [[diagnosis]].  
 
* If left untreated, most of the patients with [[hairy cell leukemia]] will gradually develop [[anemia]], recurrent [[infections]], and [[bleeding]].
* Most patients with hairy cell leukemia are asymptomatic at the time of diagnosis. If left untreated, most of the patients with hairy cell leukemia will gradually develop [[anemia]], recurrent infections, and [[bleeding]].


=== Complications ===
=== Complications ===
* Common complications of hairy cell leukemia include:
* Common [[complications]] of [[hairy cell leukemia]] include:
:* [[Anemia]]
** [[Anemia]]
:* Recurrent infections
** Recurrent [[infections]]
:* Major recurrent [[bleeding]]
** Major recurrent [[bleeding]]
:* [[Splenic rupture]]
** [[Splenic rupture]]
 
=== Prognosis ===
=== Prognosis ===
* Prognosis is generally good, and the 5-year survival rate of patients with chronic lymphocytic leukemia is approximately 90%.
* [[Prognosis]] is generally good, and the 5-year [[survival rate]] of patients with [[chronic lymphocytic leukemia]] is approximately 90%.
* Poor prognostic factors for hairy lymphocytic leukemia patients include old age, female gender, and African American race.<ref>{{Cite journal| author = [[Rekha Chandran]], [[Stuart K. Gardiner]], [[Stephen D. Smith]] & [[Stephen E. Spurgeon]]| title = Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors| journal = [[British journal of haematology]]| volume = 163| issue = 3| pages = 407–409| year = 2013| month = November| doi = 10.1111/bjh.12490| pmid = 23889044}}</ref>
* Poor [[prognostic]] factors for [[hairy cell leukemia]] patients include old age, female gender, and African American race.<ref>{{Cite journal| author = [[Rekha Chandran]], [[Stuart K. Gardiner]], [[Stephen D. Smith]] & [[Stephen E. Spurgeon]]| title = Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors| journal = [[British journal of haematology]]| volume = 163| issue = 3| pages = 407–409| year = 2013| month = November| doi = 10.1111/bjh.12490| pmid = 23889044}}</ref>
* The table below lists prognostic factors for hairy lymphocytic leukemia patients:<ref>{{cite journal |vauthors=Stewart DJ, Smith TL, Keating MJ, McCredie KB, Hersh EM, Quesada J, Freireich EJ |title=Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis) |journal=Cancer |volume=53 |issue=5 |pages=1198–1201 |year=1984 |pmid=6692307 |doi= |url=}}</ref>
* The table below lists prognostic factors for [[hairy cell leukemia]] patients:<ref>{{cite journal |vauthors=Stewart DJ, Smith TL, Keating MJ, McCredie KB, Hersh EM, Quesada J, Freireich EJ |title=Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis) |journal=Cancer |volume=53 |issue=5 |pages=1198–1201 |year=1984 |pmid=6692307 |doi= |url=}}</ref>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
| valign="top" |
| valign="top" |
Line 34: Line 32:


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Age'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Age'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* Older age at the time of diagnosis is associated with a worse prognosis.
:* Older age at the time of [[diagnosis]] is associated with a worse [[prognosis]].


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Gender'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Gender'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* Female are associated with a worse prognosis when compared to males.
:* Female are associated with a worse [[prognosis]] when compared to males.
|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Race'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Race'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* African American individuals are associated with a worse prognosis.
:* African American individuals are associated with a worse [[prognosis]].


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Infections'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" | '''Infections'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* A recent history of [[pneumonia]] or the presence of major infection at the time of diagnosis are associated with a worse prognosis.
:* A recent history of [[pneumonia]] or the presence of major infection at the time of diagnosis are associated with a worse [[prognosis]].


|-
|-

Revision as of 18:31, 13 November 2018

Hairy cell leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hairy cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hairy cell leukemia natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hairy cell leukemia natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hairy cell leukemia natural history

CDC on Hairy cell leukemia natural history

Hairy cell leukemia natural history in the news

Blogs on Hairy cell leukemia natural history

Directions to Hospitals Treating Hairy cell leukemia

Risk calculators and risk factors for Hairy cell leukemia natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Vamsikrishna Gunnam M.B.B.S [3]

Overview

Most patients with hairy cell leukemia are asymptomatic at the time of diagnosis. If left untreated, most of the patients with hairy cell leukemia will gradually develop anemia, recurrent infections, and bleeding. The complications of hairy cell leukemia are mainly due to bone marrow failure.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Prognostic Factor Description
Age
Gender
  • Female are associated with a worse prognosis when compared to males.
Race
  • African American individuals are associated with a worse prognosis.
Infections
  • A recent history of pneumonia or the presence of major infection at the time of diagnosis are associated with a worse prognosis.
Hepatomegaly
  • The presence of hepatomegaly is associated with a worse prognosis.
Hemoglobin concentration
  • A hemoglobin concentration of ≤10 g/dl is associated with a poor prognosis.
Reticulocyte count
  • A reticulocyte count of <1% is associated with a worse prognosis.
Neutrophil count
  • A neutrophil count ≤350/μl is associated with a worse prognosis.

References

  1. Rekha Chandran, Stuart K. Gardiner, Stephen D. Smith & Stephen E. Spurgeon (2013). "Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors". British journal of haematology. 163 (3): 407–409. doi:10.1111/bjh.12490. PMID 23889044. Unknown parameter |month= ignored (help)
  2. Stewart DJ, Smith TL, Keating MJ, McCredie KB, Hersh EM, Quesada J, Freireich EJ (1984). "Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis)". Cancer. 53 (5): 1198–1201. PMID 6692307.


Template:WikiDoc Sources